Prashant Yadav - Faculty Profile | INSEAD

Prashant Yadav

Technology and Operations Management

Prashant Yadav

Affiliate Professor of Technology and Operations Management

Academic Director, INSEAD Africa Initiative

Contact

Email: [email protected]
Campus: Fontainebleau

Research Areas

Supply Chains for Products with Social Benefits, Global Health Supply Chains, Supply Chain Knowledge Diffusion, Order Fulfillment, Forecasting

Teaching Areas

Pharmaceuticals and Life Sciences in Emerging Markets, Supply Chain Management in Emerging Markets, Strategy and Operations Management in Philanthropic and Nonprofit Organisations

Biography

Prashant Yadav is an Affiliate Professor of Technology and Operations Management at INSEAD. Yadav’s work focuses on improving healthcare supply chains and designing better supply chains for products with social benefits. He is the author of many peer reviewed scientific publications and his work has been featured in prominent print and broadcast media including The Economist, The Financial Times, Nature, and BBC. Yadav’s research has received best paper awards from the Production and Operations Management Society, INFORMS, and other scientific bodies. In addition to this role at INSEAD, Prashant is a Visiting Fellow at the Center for Global Development and a Lecturer at Harvard Medical School.

Before coming to INSEAD Prashant was Strategy Leader-Supply Chain at the Bill & Melinda Gates Foundation. He serves on the boards of many global organizations and social enterprises. He has been invited for expert testimony on issues related to medicine supply chains in the US Congress and legislative bodies in other countries.
Prashant obtained a PhD in Management Science from the University of Alabama and a Bachelor’s in Engineering from the Indian Institute of Technology, Roorkee.

Publications

Arinaminpathy N., Saad-Roy C. M., Yang Q., Ahmad I., Yadav P., Grenfell B. (2022). A Global System for the Next Generation of Vaccines. Science, 376(6592)

Lazarus J. V., Karim S. S. A., van Selm L., Doran J., Batista C., Ben Amor Y., Hellard M., Kim B., Kopka C. J., Yadav P. (2022). COVID-19 Vaccine Wastage in the Midst of Vaccine Inequity: Causes, Types and Practical Steps (e009010). BMJ Global Health, 7(4)

Batista C., Hotez P., Ben Amor Y., Kim J. H., Kaslow D., Lall B., Sow S. O., Kang G., Wilder-Smith A., Bottazzi M. E., Figueroa J. P., Strub-Wourgaft N., Larson H., Gursel M., Loveday S., Hassanain M., Sheahan T., Naniche D., Ergonul O., Shoham S., Yadav P., Hannay E. (2022). The Silent and Dangerous Inequity Around Access to COVID-19 Testing: A Call to Action (101230). EClinicalMedicine, 43

Karamshetty V., De Vries H., Van Wassenhove L., Dewilde S., Minnaard W., Ongarora D., Abuga K., Yadav P. (2022). Inventory Management Practices in Private Healthcare Facilities in Nairobi County. Production and Operations Management, 31(2)

Kazaz B., Webster S., Yadav P. (2022). Policy Interventions for an Agriculture-Based Malaria Medicine Supply Chain.

Gallien J., Leung N. Z., Yadav P. (2021). Inventory Policies for Pharmaceutical Distribution in Zambia: Improving Availability and Access Equity. Production and Operations Management, 30(12)

Figueroa J. P., Hotez P., Batista C., Ben Amor Y., Ergonul O., Gilbert S., Shoham S., Bottazzi M. E., Kaslow D. C., Lall B., Strub-Wourgaft N., Larson H., Gursel M., Kim J. H., Kang G., Sow S. O., Hassanain M., Naniche D., Sheahan T., Yadav P., Wilder-Smith A. (2021). Achieving Global Equity for COVID-19 Vaccines: Stronger International Partnerships and Greater Advocacy and Solidarity Are Needed (e1003772). PLOS Medicine, 18(9)

Yadav P. (2021). Childhood Cancer Medicines: Understanding Barriers to Access. The Lancet Global Health, 9(9)

Hotez P., Batista C., Ben Amor Y., Ergonul O., Figueroa J. P., Gilbert S., Shoham S., Wilder-Smith A., Bottazzi M. E., Lall B., Strub-Wourgaft N., Larson H., Gursel M., Kim J. H., Sow S. O., Kaslow D., Hassanain M., Sheahan T., Naniche D., Yadav P., Kang G. (2021). Global Public Health Security and Justice for Vaccines and Therapeutics in the COVID-19 Pandemic (101053). EClinicalMedicine, 39

Kim J. H., Hotez P., Batista C., Ergonul O., Figueroa J. P., Gilbert S., Bottazzi M. E., Lall B., Strub-Wourgaft N., Larson H., Gursel M., Shoham S., Kang G., Hassanain M., Sheahan T., Naniche D., Yadav P., Wilder-Smith A. (2021). Operation Warp Speed: Implications for Global Vaccine Security. The Lancet Global Health, 9(7)

Naniche D., Hotez P., Bottazzi M. E., Ergonul O., Figueroa J. P., Gilbert S., Shoham S., Wilder-Smith A., Lall B., Strub-Wourgaft N., Larson H., Gursel M., Kim J. H., Batista C., Sow S. O., Kaslow D., Hassanain M., Sheahan T., Yadav P., Kang G. (2021). Beyond the Jab: A Need for Global Coordination of Pharmacovigilance for COVID-19 Vaccine Deployment (100925). EClinicalMedicine, 36

Batista C., Shoham S., Ergonul O., Hotez P., Bottazzi M. E., Figueroa J. P., Wilder-Smith A., Gilbert S., Lall B., Strub-Wourgaft N., Larson H., Gursel M., Kim J. H., Sow S. O., Kaslow D., Hassanain M., Sheahan T., Naniche D., Yadav P., Kang G. (2021). Urgent Needs to Accelerate the Race for COVID-19 Therapeutics (100911). EClinicalMedicine, 36

Hotez P., Batista C., Ergonul O., Figueroa J. P., Gilbert S., Gursel M., Bottazzi M. E., Lall B., Strub-Wourgaft N., Larson H., Kim J. H., Shoham S., Kang G., Hassanain M., Sheahan T., Naniche D., Yadav P., Wilder-Smith A. (2021). Correcting COVID-19 Vaccine Misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members (100780). EClinicalMedicine, 33

Figueroa J. P., Bottazzi M. E., Hotez P., Batista C., Ergonul O., Gilbert S., Lall B., Strub-Wourgaft N., Larson H., Gursel M., Kim J. H., Shoham S., Wilder-Smith A., Hassanain M., Sheahan T., Naniche D., Yadav P., Kang G. (2021). Urgent Needs of Low-Income and Middle-Income Countries for COVID-19 Vaccines and Therapeutics . The Lancet, 397(10274)

Gooding E., Spiliotopoulou E., Yadav P. (2019). Impact of vaccine stockouts on immunization coverage in Nigeria. Vaccine, 37(35)

Vledder M., Friedman J., Sjoblom M., Brown T., Yadav P. (2019). Improving Supply Chain for Essential Drugs in Low-Income Countries: Results from a Large Scale Randomized Experiment in Zambia. Health Systems & Reform, 5(2)

Yadav P., Alphs S., D'Souza C., Comstock G., Barton I. (2018). Local Sourcing and Supplier Development in Global Health: Analysis of the Supply Chain Management System's Local Procurement in 4 Countries. Global Health: Science and Practice, 6(3)

Yadav P., Weintraub R. L., Stergachis A. (2018). When Government Agencies Turn to Unregulated Drug Sources: Implications for the Drug Supply Chain and Public Health Are Grave. Journal of the American Pharmacists Association, 58(5)

Bloom B. R., Atun R., Cohen T., Dye C., Fraser H., Gomez G. B., Nardell E., Murray M., Vassall A., Wilson D., Rubin E., Volchenkov G., Yadav P., Salomon J., White R., Knight G. (2017). Tuberculosis.

Gallien J., Rashkova I., Atun R., Yadav P. (2017). National Drug Stockout Risks and the Global Fund Disbursement Process for Procurement. Production and Operations Management, 26(6)

Wirtz V. J., Hogerzeil H. V., Gray A. L., Bigdeli M., de Joncheere C. P., Ewen M. A., Reich M. R., Moller H., Hoen E. F. M. �., Wagner A. K., Mbindyo R. M., Jing S., Rago L., Stephens P. N., Teerawattananon Y., Rashidian A., Ross-Degnan D., Pecoul B., Moucheraud C., Luiza V. L., Yadav P., Gyansa-Lutterodt M. (2017). Essential Medicines for Universal Health Coverage. The Lancet, 389(10067)

Kazaz B., Webster S., Yadav P. (2016). Interventions for an Artemisinin‐Based Malaria Medicine Supply Chain. Production and Operations Management, 25(9)

Agrawal P., Barton I., dal Bianco R., Hovig D., Sarley D., Yadav P. (2016). Moving Medicine, Moving Minds: Helping Developing Countries Overcome Barriers to Outsourcing Health Commodity Distribution to Boost Supply Chain Performance and Strengthen Health Systems. Global Health: Science and Practice, 4(3)

Berenguer G., Iyer A. V., Yadav P. (2016). Disentangling the Efficiency Drivers in Country-Level Global Health Programs: An Empirical Study. Journal of Operations Management, 45

Leung N. Z., Chen A., Yadav P., Gallien J. (2016). The Impact of Inventory Management on Stock-Outs of Essential Drugs in Sub-Saharan Africa: Secondary Analysis of a Field Experiment in Zambia. PLOS One, 11(5)

Visser T., Daily J., Hotte N., Dolkart C., Cunningham J., Yadav P. (2015). Rapid Diagnostic Tests for Malaria. Bulletin of the World Health Organization, 93(12)

Yadav P. (2015). Health Product Supply Chains in Developing Countries: Diagnosis of the Root Causes of Underperformance and an Agenda for Reform. Health Systems & Reform, 1(2)

Shretta R., Johnson B., Smith L., Doumbia S., de Savigny D., Anupindi R., Yadav P. (2015). Costing the Supply Chain for Delivery of Act and Rdts in the Public Sector in Benin and Kenya. Malaria Journal, 14(1)

Yadav P., Lydon P., Oswald J., Dicko M., Zaffran M. (2014). Integration of Vaccine Supply Chains with Other Health Commodity Supply Chains: A Framework for Decision Making. Vaccine, 32(50)

Arney L., Yadav P., Miller R., Wilkerson T. (2014). Strategic Contracting Practices to Improve Procurement of Health Commodities. Global Health: Science and Practice, 2(3)

Yadav P., Alphs S., Hotte N. (2014). Parasite-Based Diagnosis and Its Impact on Health Systems.

Pai M., Yadav P., Anupindi R. (2014). Tuberculosis Control Needs a Complete and Patient-Centric Solution. The Lancet Global Health, 2(4)

Yadav P., Smith L. (2014). Pharmaceutical Company Strategies and Distribution Systems in Emerging Markets.

Yadav P., Smith L. (2014). Pharmaceuticals and National Health Systems.

Smith L., Yadav P. (2014). Improving Access to Medicines for Non-Communicable Diseases Through Better Supply Chains.

Larson P. S., Yadav P., Alphs S., Arkedis J., Massaga J., Sabot O., Cohen J. L. (2013). Diffusion of Subsidized Acts in Accredited Drug Shops in Tanzania: Determinants of Stocking and Characteristics of Early and Late Adopters. BMC Health Services Research, 13(1)

Cohen J. L., Yadav P., Moucheraud C., Alphs S., Larson P. S., Arkedis J., Massaga J., Sabot O. (2013). Do Price Subsidies on Artemisinin Combination Therapy for Malaria Increase Household Use?: Evidence from a Repeated Cross-Sectional Study in Remote Regions of Tanzania. PLOS One, 8(7)

Spiliotopoulou E., Boni M. F., Yadav P. (2013). Impact of Treatment Heterogeneity on Drug Resistance and Supply Chain Costs. Socio-Economic and Planning Sciences, 47(3)

Zaffran M., Vandelaer J., Kristensen D., Melgaard B., Yadav P., Antwi-Agyei K. O., Lasher H. (2013). The Imperative for Stronger Vaccine Supply and Logistics Systems. Vaccine, 31(suppl 2)

Kraiselburd S., Yadav P. (2013). Supply Chains and Global Health: An Imperative for Bringing Operations Management Scholarship into Action. Production and Operations Management, 22(2)

Yadav P., Stapleton O., Van Wassenhove L. (2013). Learning from Coca-Cola . Stanford Social Innovation Review, 11(1)

Shretta R., Yadav P. (2012). Stabilizing Supply of Artemisinin and Artemisinin-Based Combination Therapy in an Era of Wide-Spread Scale-Up. Malaria Journal, 11(1)

Samii A., Pibernik R., Yadav P., Vereecke A. (2012). Reservation and Allocation Policies for Influenza Vaccines. European Journal of Operational Research, 222(3)

Yadav P., Cohen J. L., Alphs S., Arkedis J., Larson P. S., Massaga J., Sabot O. (2012). Trends in Availability and Prices of Subsidized Act over the First Year of the AMFm: Evidence from Remote Regions of Tanzania. Malaria Journal, 11(1)

Yadav P., Smith R. D., Hanson K. (2012). Pharmaceuticals and the Health Sector.

Samii A., Pibernik R., Yadav P. (2011). An Inventory Reservation Problem with Nesting and Fill Rate-Based Performance Measures. International Journal of Production Economics, 133(1)

Yadav P. (2010). Improving Public Health In Developing Countries Through Operations Research.

Cases with Extra

Personal Website

Our website has a lot of features which will not display correctly without Javascript.

Please enable Javascript in your browser

Here how you can do it: http://enable-javascript.com